PASSERI DANIEL R
SEC insider (Form 3/4/5 filer). CIK 0001190121. CHIEF EXECUTIVE OFFICER at Cue Biopharma, Inc. (CUE). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 21, 2025. Located in BOSTON, MA.
Companies PASSERI DANIEL R has filed insider reports for
- Cue Biopharma, Inc. (CUE): Director, Officer, CHIEF EXECUTIVE OFFICER
PASSERI DANIEL R
CIK: 0001190121
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CUE
Cue Biopharma, Inc.
DirectorOfficer